Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Sewon Park, Han-Kyoul Kim, Haeng-Jun Lee, Mankyu Choi, Munjae Lee & Mihajlo Jakovljevic. (2023) Strategic management and organizational culture of medical device companies in relation to corporate performance. Journal of Medical Economics 26:1, pages 781-792.
Read now
Read now
Binaya Sapkota, Subish Palaian, Sunil Shrestha, Akihiko Ozaki, Mohamed Izham Mohamed Ibrahim & Mihajlo Jakovljevic. (2022) Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region. Expert Review of Pharmacoeconomics & Outcomes Research 22:7, pages 1043-1050.
Read now
Read now
Mihajlo Jakovljevic, Wenqing Wu, Joav Merrick, Arcadio Cerda, Mirjana Varjacic & Takuma Sugahara. (2021) Asian innovation in pharmaceutical and medical device industry – beyond tomorrow. Journal of Medical Economics 24:sup1, pages 42-50.
Read now
Read now
Mihajlo Jakovljevic, Takuma Sugahara, Yuriy Timofeyev & Nemanja Rancic. (2020) Predictors of (in)efficiencies of Healthcare Expenditure Among the Leading Asian Economies – Comparison of OECD and Non-OECD Nations. Risk Management and Healthcare Policy 13, pages 2261-2280.
Read now
Read now
Vladimir Reshetnikov, Oleg Mitrokhin, Nataliya Shepetovskaya, Elena Belova & Mihajlo Jakovljevic. (2020) Organizational measures aiming to combat COVID-19 in the Russian Federation: the first experience. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 571-576.
Read now
Read now
Viktorija Dragojević-Simić, Aleksandra Kovačević, Vesna Jaćević, Nemanja Rančić, Snežana Djordjević, Vesna Kilibarda, Momir Mikov & Dubravko Bokonjić. (2018) Bioequivalence study of two formulations of itraconazole 100 mg capsules in healthy volunteers under fed conditions: a randomized, three-period, reference-replicated, crossover study. Expert Opinion on Drug Metabolism & Toxicology 14:9, pages 979-988.
Read now
Read now
Hirohisa Shimura. (2018) Sales promotion by wholesalers affects general practitioners’ prescription behaviours in Japan. Journal of Market Access & Health Policy 6:1.
Read now
Read now
Jörg Mahlich, Masamichi Nishi & Yoshimichi Saito. (2015) Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan. ClinicoEconomics and Outcomes Research 7, pages 267-272.
Read now
Read now
Mihajlo B Jakovljevic, Natasa Djordjevic, Milena Jurisevic & Slobodan Jankovic. (2015) Evolution of the Serbian pharmaceutical market alongside socioeconomic transition. Expert Review of Pharmacoeconomics & Outcomes Research 15:3, pages 521-530.
Read now
Read now
Mihajlo B Jakovljevic, Thomas E Getzen, Aleksandra Torbica & Tomofumi Anegawa. (2014) 10th World IHEA and ECHE joint congress: Health Economics in the Age of Longevity. Expert Review of Pharmacoeconomics & Outcomes Research 14:6, pages 781-783.
Read now
Read now
Articles from other publishers (23)
Yudai Kaneda, Akihiko Ozaki, Takanao Hashimoto, Yosuke Suzuki, Hiroaki Saito, Tetsuya Tanimoto, Erika Yamashita & Mihajlo Jakovljevic. (2023) Characteristics of Top-Searched Individuals in Japan’s Yen for Docs Conflicts of Interest Database During the COVID-19 Pandemic. Cureus.
Crossref
Crossref
Mihajlo Jakovljevic, Demetrios Lamnisos, Ronny Westerman, Vijay Kumar Chattu & Arcadio Cerda. (2022) Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications. Health Research Policy and Systems 20:1.
Crossref
Crossref
Dong‐Sook Kim, Jihye Shin & Jusun Chung. (2021) Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines. Clinical and Translational Science 15:2, pages 433-441.
Crossref
Crossref
Shine Stephen, Alwin Issac, Rakesh Vadakkethil Radhakrishnan, Jaison Jacob, VR Vijay, Sam Jose, SM Azhar, Anoop S. Nair, Nadiya Krishnan, Rakesh Sharma & Manju Dhandapani. (2021) Scrutiny of COVID-19 response strategies among severely affected European nations. Osong Public Health and Research Perspectives 12:4, pages 203-214.
Crossref
Crossref
Paramjeet Malik, Neelam Pawar & Kavita Bahmani. (2021) Regulatory Requirements and Comparison of Approval of New and Generic Drugs in the United States of America and Japan: Implication for Future Strategies. Applied Drug Research, Clinical Trials and Regulatory Affairs 8:1, pages 32-47.
Crossref
Crossref
Natalie S. Hohmann, Kimberly B. Garza, Daniel Surry, Richard A. Hansen, Ilene Harris, Zippora Kiptanui, Oluwamurewa Oguntimein, Mitchell M. Frost & Jingjing Qian. (2020) Healthcare provider opinions about a generic drug educational newsletter. Research in Social and Administrative Pharmacy 16:9, pages 1228-1236.
Crossref
Crossref
Nenad Miljković, Brian Godman, Eline van Overbeeke, Milena Kovačević, Karyofyllis Tsiakitzis, Athina Apatsidou, Anna Nikopoulou, Cristina Garcia Yubero, Laura Portillo Horcajada, Gunar Stemer, Darija Kuruc-Poje, Thomas De Rijdt, Tomasz Bochenek, Isabelle Huys & Branislava Miljković. (2020) Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals. Frontiers in Medicine 7.
Crossref
Crossref
Jeewon Park, SeungJin Bae, Tae-Jin Lee & Kyung-Bok Son. (2020) Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate. Frontiers in Pharmacology 11.
Crossref
Crossref
Shoyo Shibata, Maiko Matsushita, Yoshimasa Saito & Takeshi Suzuki. (2018) Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan. Therapeutic Innovation & Regulatory Science 52:4, pages 442-448.
Crossref
Crossref
Takefumi Hosoda, Jay R. Fraser, Myung-Sook Kim & Hongsik John Cheon. (2018) Consumer Behavioral Systems to Approach or Avoid Generic Medicine (GM) Consumption in Japan. The Journal of Asian Finance, Economics and Business 5:2, pages 105-118.
Crossref
Crossref
Mohamed Azmi Hassali & Zhi Yen Wong. 2018. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries. Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries
197
210
.
Mihajlo Jakovljevic & Tetsuji Yamada. (2017) Editorial: Role of Health Economic Data in Policy Making and Reimbursement of New Medical Technologies. Frontiers in Pharmacology 8.
Crossref
Crossref
Takefumi Hosoda & Hongsik J. Cheon. 2017. Advanced Multimedia and Ubiquitous Engineering. Advanced Multimedia and Ubiquitous Engineering
277
282
.
Anthony Pezzola & Cassandra M. Sweet. (2016) Global pharmaceutical regulation: the challenge of integration for developing states. Globalization and Health 12:1.
Crossref
Crossref
François Bocquet, Anaïs Loubière, Isabelle Fusier, Anne-Laure Cordonnier & Pascal Paubel. (2016) Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. PharmacoEconomics 34:11, pages 1173-1186.
Crossref
Crossref
Aleksandra Kovacevic, Nemanja Rancic, Zoran Segrt & Viktorija Dragojevic-Simic. (2016) Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia. Frontiers in Pharmacology 7.
Crossref
Crossref
Zhi Yen Wong, Alian A. Alrasheedy, Mohamed Azmi Hassali & Fahad Saleem. (2016) Generic medicines in the Malaysian health care system: Opportunities and challenges. Research in Social and Administrative Pharmacy 12:5, pages 807-810.
Crossref
Crossref
Mihajlo Jakovljevic. (2016) Commentary: Patient Cost Sharing and Medical Expenditures for the Elderly. Frontiers in Pharmacology 7.
Crossref
Crossref
Mihajlo Jakovljevic, Marija Lazarevic, Olivera Milovanovic & Tatjana Kanjevac. (2016) The New and Old Europe: East-West Split in Pharmaceutical Spending. Frontiers in Pharmacology 7.
Crossref
Crossref
Veselin Dickov. (2015) Peculiarity of Pharmaceutical Marketing in Serbia. Frontiers in Public Health 3.
Crossref
Crossref
Vojislav Cupurdija. (2015) Economic Impact of Leading Prosperity Diseases: COPD in South East Europe. Frontiers in Public Health 3.
Crossref
Crossref
François Bocquet, Pascal Paubel, Isabelle Fusier, Anne-Laure Cordonnier, Martine Sinègre & Claude Le Pen. (2014) Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience. Applied Health Economics and Health Policy 13:1, pages 47-59.
Crossref
Crossref
Mihajlo B. Jakovljevic. (2014) The Key Role of the Leading Emerging Bric Markets in the Future of Global Health Care. Serbian Journal of Experimental and Clinical Research 15:3, pages 139-143.
Crossref
Crossref